No Picture
News

Novavax Announces Initiation of Phase 2 Trial for COVID-19-Influenza Combination and Stand-Alone Influenza Vaccine Candidates

GAITHERSBURG, Md., Dec. 30, 2022 /PRNewswire/ — Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced the initiation of a Phase 2 trial for […]

Advertise With Biotech Networks
No Picture
News

Novavax Announces Closing of $175.25 Million Offering of Convertible Senior Notes Due 2027 and $74.75 Million Public Offering of Common Stock

GAITHERSBURG, Md., Dec. 28, 2022 /PRNewswire/ — On December 20, 2022, Novavax, Inc. (Nasdaq: NVAX), a biotechnology company (the “Company” or “Novavax”) dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, completed the […]

Advertise With Biotech Networks
No Picture
News

Peraton Awarded $1.7B to Provide IT Professional Services to National Institutes of Health’s National Cancer Institute

The agency’s work supports advances in cancer detection, diagnosis, and care and contributes to declining rates of cancer-related deaths and new cancer cases in the U.S. RESTON, Va., Dec. 28, 2022 /PRNewswire/ — Peraton has […]

Advertise With Biotech Networks